Oncopath SRL
Oncopath reported total assets of 418,854 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Oct 2026).
The score of Oncopath shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -6 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oncopath's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Oct 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
Oncopath's financial analysis
- Solvency47.2%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oncopath
Oncopath's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0568.915.292
- VAT number
- BE0568915292
- Peppol
- Registered · 0208:0568915292 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Jan 2015
- Registered office
- 1440 Braine-le-Château
- Latest accounts
- 2025 · filed on 14 Oct 2026
- Activity
- Medical specialists activities (NACE 86220)
Oncopath (SRL) has been based in Braine-le-Château since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 85,312 € and equity of 197,897 €; its revenue is not published. Its solvency stands at 47.2%, below the median of its sector (65.0%).
Companies similar to Oncopath
Companies in the same business, of comparable size and area, outside its group.
- DR Egüz Medical specialists activities Waterloo · balance sheet 346,210 €
- Docteur Nicolas Berg Medical specialists activities Liège · balance sheet 422,669 €
- Oncolux Medical specialists activities Meix-devant-Virton · balance sheet 422,800 €
- DR. Vermeiren - DR. Thibaut Medical specialists activities Mortsel · balance sheet 523,297 €
- Dr Hendrickx - Dr Lequesne Medical specialists activities Mortsel · balance sheet 484,116 €
- IMPROVING KIDNEY HEALTH co Medical specialists activities Tervuren · balance sheet 407,383 €
- Ortho Medic Kurth Medical specialists activities Blegny · balance sheet 428,512 €
- Dokter Vermeiren ANN Medical specialists activities Turnhout · balance sheet 438,024 €
Frequently asked questions about Oncopath
What is the revenue of Oncopath?
Oncopath files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oncopath?
In Belgium, the VAT number is the company number prefixed with BE: BE0568915292 for Oncopath, if the company is VAT-registered. Its company number (CBE) is 0568.915.292.
Where is the registered office of Oncopath?
According to the CBE register, the registered office of Oncopath is in 1440 Braine-le-Château.
What is the equity of Oncopath?
At the close of the 2025 financial year, the equity of Oncopath amounts to 197,897 €, a solvency of 47.2% of total assets.
Who manages Oncopath?
The register lists 1 active mandates at Oncopath. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oncopath
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →